Aureate Tradde IPO Day 1: GMP ₹0

The Aureate Tradde BSE SME IPO kicked off today, May 29th, 2026, and it’s been a remarkably quiet start. As of the end of Day 1, we’re seeing zero subscriptions across all categories. Yes, you read that right – zero applications have been received from Retail, Non-Institutional Investors (NII), or Qualified Institutional Buyers (QIB). This is certainly an unusual beginning for any IPO, let alone an SME offering.

Subscription Status

Let’s dive into the numbers, or rather, the lack thereof. The total subscription stands at a flat 0x. This means that not a single share has been subscribed for by any investor segment. For the Retail category, which typically sees a good chunk of applications in SME IPOs, the subscription is 0x. Similarly, NIIs, who often participate in larger numbers for SME issues to gain exposure, have also not yet shown their hand, with 0x subscription. Most interestingly, even the QIB segment, which usually comprises institutional investors, is at 0x. Typically, strong QIB interest can be a good indicator of institutional confidence. However, in this initial phase, a zero subscription across the board doesn’t necessarily spell doom. It’s quite common for subscription numbers to pick up significantly on the latter days of an IPO, especially for SME issues. Many investors prefer to wait and observe the initial response before committing their capital. So, while it’s a bit unusual, it’s not entirely unexpected at this early stage. This could concern investors looking for immediate momentum, but it’s too soon to draw firm conclusions.

GMP Update

Now, let’s talk about the Grey Market Premium (GMP). Today, the Current GMP for Aureate Tradde IPO is ₹0. This is unchanged from yesterday’s GMP, which was also ₹0. A GMP of ₹0 suggests that the market sentiment is currently neutral, with no immediate premium being bid for the shares over the issue price. The expected listing price, based on this GMP, remains at the issue price of ₹70. It’s important to remember that GMP is an unofficial indicator and can be highly volatile. However, a consistent zero GMP on Day 1 of subscription, especially when the issue price is ₹70, doesn’t offer much of a speculative upside right now. This could be a factor contributing to the subdued subscription numbers, as potential investors might be waiting for clearer market signals or a positive shift in GMP.

Should You Apply?

So, the big question: should you apply for the Aureate Tradde SME IPO? Based on Day 1’s data, it’s a mixed bag. On one hand, the subscription is non-existent, and the GMP is flat at zero, indicating no immediate market excitement. This might deter risk-averse investors or those looking for quick listing gains. However, that said, it’s only Day 1. Many SME IPOs see a surge in applications towards the closing days. Investors might be adopting a wait-and-watch approach, especially given the current market dynamics. The issue price is ₹70, and with a lot size of 2000 shares, it’s a significant investment for retail investors. The IPO period runs until June 2nd, 2026, giving potential applicants ample time to evaluate. As per SEBI advisor guidelines, it’s always recommended to conduct thorough due diligence, understand the company’s fundamentals, and assess your risk appetite before investing. Don’t just rely on GMP or initial subscription data. Consider the company’s business model, financial health, and future prospects. For those who believe in the company’s long-term vision and are comfortable with the risk associated with SME listings, this subdued start might even present an opportunity to invest without intense competition.

You can view the full Aureate Tradde IPO details here: View Full Aureate Tradde IPO Details